Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Gäddnäs, Fiia P ^a   Sutinen, Meeri M ^a   Koskela, Marjo ^a   Tervahartiala, Taina ^b   Sorsa, Timo ^b   Salo, Tuula A ^a   Laurila, Jouko J ^a   Koivukangas, Vesa ^a   Ala Kokko, Tero I ^a   Oikarinen, Aarne ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GELATINASE A; GELATINASE B; HYPERTENSIVE FACTOR; NEUTROPHIL COLLAGENASE; MATRIX METALLOPROTEINASE;

ADULT; AGED; ARTICLE; BLISTER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SUCTION; SURVIVOR; UPREGULATION; BLOOD; DISEASE COURSE; HOSPITALIZATION; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SKIN;

AGED; BLISTER; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MATRIX METALLOPROTEINASES, SECRETED; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; SKIN; UP-REGULATION;

EID: 77950421338     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8938     Document Type: Article

References (34)

1. Reijerkerk A, Kooij G, Pol SM, Khazen S, Dijkstra CD, de Vries HE. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J 2006, 20:2550-2552. 10.1096/fj.06-6099fje, 17065217.
2. Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000, 96:2673-2681.
3. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002, 100:1160-1167.
4. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14:163-176. 316345, 10652271.
5. Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998, 161:3340-3346.
6. Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, Sasaguri Y, Mori Y. Degradation of interleukin 1 beta by matrix metalloproteinases. J Biol Chem 1996, 271:14657-14660. 10.1074/jbc.271.25.14657, 8663297.
7. Owen CA, Hu Z, Lopez-Otin C, Shapiro SD. Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase andserpinase-1. J Immunol 2004, 172:7791-7803.
8. Gutiérrez-Fernández A, Inada M, Balbín M, Fueyo A, Pitiot AS, Astudillo A, Hirose K, Hirata M, Shapiro SD, Noël A, Werb Z, Krane SM, López-Otín C, Puente XS. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 2007, 21:2580-2591. 10.1096/fj.06-7860com, 2575772, 17392479.
9. Nakamura T, Ebihara I, Shimada N, Shoji H, Koide H. Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: Effect of fiber-immobilized polymyxin B treatment. Am J Med Sci 1998, 316:355-360. 10.1097/00000441-199812000-00001, 9856688.
10. Hoffmann U, Bertsch T, Dvortsak E, Liebetrau C, Lang S, Liebe V, Huhle G, Borggrefe M, Brueckmann M. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: Prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 2006, 38:867-872. 10.1080/00365540600702058, 17008230.
11. Lorente L, Martín MM, Labarta L, Díaz C, Solé-Violán J, Blanquer J, Orbe J, Rodríguez JA, Jiménez A, Borreguero-León JM, Belmonte F, Medina JC, Llimiñana MC, Ferrer-Agüero JM, Ferreres J, Mora ML, Lubillo S, Sánchez M, Barrios Y, Sierra A, Páramo JA. Matrix metalloproteinase -9. -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 2009, 13:R158. 10.1186/cc8115, 2784384, 19799791.
12. Hästbacka J, Hynninen M, Kolho E, Pettilä V, Tervahartiala T, Sorsa T, Lauhio A. Collagenase 2/matrix metalloproteinase 8 in critically ill patients with secondary peritonitis. Shock 2007, 27:145-150. 10.1097/01.shk.0000239771.10528.d3, 17224788.
13. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968, 50:129-137.
14. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. the ACCP/SCCM consensus conference committee. american college of chest Physicians/Society of critical care medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
15. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure on behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
16. Vermeer BJ, Reman FC, van Gent CM. The determination of lipids and proteins in suction blister fluid. J Invest Dermatol 1979, 73:303-305. 10.1111/1523-1747.ep12531833, 479634.
17. Oikarinen A, Kylmäniemi M, Autio-Harmainen H, Autio P, Salo T. Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: Variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol 1993, 101:205-210. 10.1111/1523-1747.ep12363823, 8345222.
18. O'Grady RL, Nethery A, Hunter N. A fluorescent screening assay for collagenase using collagen labeled with 2-methoxy-2,4-diphenyl-3(2H)-furanone. Anal Biochem 1984, 140:490-494. 10.1016/0003-2697(84)90199-4, 6091495.
19. Hemmilä I, Dakubu S, Mukkala VM, Siitari H, Lovgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984, 137:335-343. 10.1016/0003-2697(84)90095-2, 6375455.
20. Gäddnäs F, Koskela M, Koivukangas V, Risteli J, Oikarinen A, Laurila J, Saarnio J, Ala-Kokko T. Markers of collagen synthesis and degradation are increased in serum in severe sepsis: A longitudinal study of 44 patients. Crit Care 2009, 13:R53. 10.1186/cc7780, 2689500, 19358720.
21. McGill SN, Ahmed NA, Hu F, Michel RP, Christou NV. Shedding of L-selectin as a mechanism for reduced polymorphonuclear neutrophils exudation in patients with the systemic inflammatory response syndrome. Arch Surg 1996, 131:1141-1146.
22. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VW, Helaakoski T, Kainulainen T, Rönkä H, Tschesche H, Salo T. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells: regulation by tumor necrosis factor-a and doxycycline. J Biol Chem 1997, 272:31504. 10.1074/jbc.272.50.31504, 9395486.
23. Pugin J, Widmer MC, Kossodo S, Liang CM, Preas HL, Suffredini AF. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 1999, 20:458-464.
24. Paemen L, Jansen PM, Proost P, Van Damme J, Opdenakker G, Hack E, Taylor FB. Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. Cytokine 1997, 9:412-415. 10.1006/cyto.1996.0183, 9199875.
25. Alves-Filho JC, de Freitas A, Spiller F, Souto FO, Cunha FQ. The role of neutrophils in severe sepsis. Shock 2008, 30(Suppl 1):3-9. 10.1097/SHK.0b013e3181818466, 18704017.
26. Jansen PL, Rosch R, Jansen M, Binnebösel M, Junge K, Alfonso-Jaume A, Klinge U, Lovett DH, Mertens PR. Regulation of MMP-2 gene transcription in dermal wounds. J Invest Dermatol 2007, 127:1762-1767.
27. Han YP, Tuan TL, Wu H, Hughes M, Garner WL. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 2001, 114:131-139. 2435089, 11112697.
28. Koskela M, Gäddnäs F, Ala-Kokko TI, Laurila JJ, Saarnio J, Oikarinen A, Koivukangas V. Epidermal wound healing in severe sepsis and septic shock in humans. Crit Care 2009, 13:R100. 10.1186/cc7932, 2717472, 19552820.
29. Wohlschlaeger J, Stubbe HD, Schmitz KJ, Kawaguchi N, Takeda A, Takeda N, Hinder F, Baba HA. Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model. Pathol Res Pract 2005, 201:809-817. 10.1016/j.prp.2005.08.009, 16308106.
30. Torii K, Iida K, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, Taki F, Takagi K, Matsuyama M, Suzuki R. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 1997, 155:43-46.
31. Xue M, Thompson P, Kelso I, Jackson C. Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes. Exp Cell Res 2004, 299:119-127. 10.1016/j.yexcr.2004.05.015, 15302579.
32. Xue M, March L, Sambrook PN, Jackson CJ. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: Relevance to inflammation in rheumatoid arthritis. Arthritis Rheum 2007, 56:2864-2874. 10.1002/art.22844, 17763449.
33. Aljada A, Ghanim H, Mohanty P, Hofmeyer D, Tripathy D, Dandona P. Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9). J Clin Endocrinol Metab 2001, 86:5988-5991. 10.1210/jc.86.12.5988, 11739475.
34. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000, 26 Suppl 1:S64-S74. 10.1007/s001340051121, 10786961.